In the fiscal year 2009, the Dräger share developed weaker than the market overall. Although the share price on December 30, 2009, was up on the level at the beginning of the year (+15 percent), it was unable to keep pace with the overall development of the DAX (+20 percent) and the TecDAX (+56 percent).
On the first day of trading in 2009, the Dräger share was worth EUR 26.08. By February 19, 2009, when Dräger published an ad-hoc release outlining the possible buy-back of the 25 percent stake in Dräger Medical AG & Co. KG, the share price had fallen to EUR 20.69. On the back of reporting the preliminary figures for 2008 on February 24, 2009, the price fell further to EUR 17.54. Although the stock markets recovered somewhat in March, the Dräger share was unable to latch on to this development and recorded its low for the year on March 11, 2009, with EUR 13.28. On March 19, 2009, the day the final figures for 2008 were published, the share was trading at EUR 14.86. Up to the publication of the first quarter report on May 6 and the annual shareholders’ meeting on May 8, 2009, the price rose to around EUR 20 with volatile overall development. After the turnaround program was announced on June 15, 2009, and another minor market downturn, the Dräger share price fell again to EUR 17.59. It was able to recover somewhat to EUR 20.40 by the time the half-yearly financial report was released on August 6, 2009. Following extraordinarily upbeat share development in September and the start of October 2009, the share price was trading at EUR 29.90 by the time the third quarter report was released on November 5, 2009. On December 15, 2009, the Dräger share recorded its annual high at EUR 31.80 and closed the year at EUR 29.89 following the ad-hoc reporting on taking over the minority share in Dräger Medical AG & Co. KG on December 29, 2009.